ArmorSource Introduces All U.S.-Made Enhanced Trauma-Reducing Ballistic Helmet
Buy American: First-Ever Made-in-USA Helmet Meets Highest German Standard, Now Available to U.S. Law Enforcement
HEBRON, OHIO / ACCESS Newswire / May 20, 2025 / ArmorSource, a leading manufacturer of advanced ballistic head protection, proudly announces the launch of the AS-223 - a groundbreaking ballistic helmet engineered and built entirely in the United States. Designed with U.S. law enforcement in mind, the AS-223 sets a new standard in trauma reduction, ballistic performance and comfort.
The AS-223 is the first U.S.-made helmet to exceed the ballistic requirements of the most demanding international and domestic standards, including:
U.S. DEA/FBI Ballistic ProtocolsGerman VPAM-3 - the highest European standard for head protectionNIJ Level IIIA (National Institute of Justice, USA)
Built with the proven Advanced Combat Helmet geometry, the AS-223 delivers minimal back-face deformation in the event of ballistic impact, significantly reducing the risk of blunt trauma to officers in the line of duty. Unlike other "one-size-fits-all" systems available, the ArmorSource helmet is offered in four sizes providing a comfortable fit tailored to the user. The regular, mid, and high-cut profiles are available with both bolted and boltless configurations to meet mission-specific needs.
"We designed the AS-223 specifically for the needs of U.S. law enforcement," said Pete Costanzo, Director of Sales, North America at ArmorSource. "It's a premium ballistic helmet system that was previously only available as an import from Europe. Now, like all ArmorSource head protection systems, the AS-223 is fully produced in Hebron, Ohio, using American manufacturing and technology."
Previously, helmets capable of meeting the rigorous German VPAM-3 standard were manufactured exclusively in Europe, with some units imported in pieces and assembled in the U.S. With the AS-223, ArmorSource becomes the first American manufacturer to fully construct VPAM-3-certified helmets on U.S. soil - making this high-level protection system more accessible to domestic law enforcement agencies without relying on imports.
ArmorSource is a trusted provider of ballistic head protection to U.S. military and law enforcement organizations, as well as global partners across Europe and beyond. The company's next-generation helmets offer ultra-lightweight protection with enhanced ballistic, environmental, and mechanical performance.
For more information or to request a demo of the AS-223 helmet, please contact:Pete CostanzoDirector of Sales, North AmericaEmail: pcostanzo@armorsource.comPhone: 740-928-0070 X129
SOURCE: ArmorSource, LLC.
press release
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
35 minutes ago
- Yahoo
European Penny Stocks To Watch In June 2025
European markets have seen a modest uptick, with the STOXX Europe 600 Index gaining 0.65% as optimism grows over potential trade negotiations and slowing inflation prompts expectations of an interest rate cut by the European Central Bank. As investors navigate these evolving conditions, penny stocks—often smaller or newer companies—remain an intriguing option for those seeking growth opportunities outside the mainstream indices. Despite being considered a relic of past market eras, penny stocks continue to offer potential when backed by strong financial health, making them worth watching for their affordability and growth prospects. Name Share Price Market Cap Financial Health Rating Bredband2 i Skandinavien (OM:BRE2) SEK2.325 SEK2.23B ★★★★☆☆ KebNi (OM:KEBNI B) SEK1.818 SEK492.96M ★★★★★★ Angler Gaming (NGM:ANGL) SEK3.69 SEK276.69M ★★★★★★ Hifab Group (OM:HIFA B) SEK3.64 SEK221.45M ★★★★★★ Abak (WSE:ABK) PLN4.20 PLN11.32M ★★★★★★ Cellularline (BIT:CELL) €2.93 €61.8M ★★★★★☆ Netgem (ENXTPA:ALNTG) €0.948 €31.75M ★★★★★★ Fondia Oyj (HLSE:FONDIA) €4.67 €17.46M ★★★★★★ Mistral Iberia Real Estate SOCIMI (BME:YMIB) €1.01 €22M ★★★★★☆ Deceuninck (ENXTBR:DECB) €2.17 €299.6M ★★★★★★ Click here to see the full list of 447 stocks from our European Penny Stocks screener. Let's dive into some prime choices out of the screener. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Antares Vision S.p.A. specializes in the production, installation, and maintenance of inspection systems for quality control and has a market cap of €320.63 million. Operations: The company's revenue segment includes Industrial Automation & Controls, which generated €207.66 million. Market Cap: €320.63M Antares Vision S.p.A. has a market cap of €320.63 million and reported sales of €207.49 million for 2024, though it remains unprofitable with a net loss of €18.77 million. Despite this, the company maintains a sufficient cash runway exceeding three years, supported by positive free cash flow and stable short-term assets (€176.4M) that cover both short-term (€109.6M) and long-term liabilities (€150.2M). However, its management team is relatively new with an average tenure of 1.4 years, and the net debt to equity ratio is high at 45.2%. Earnings are forecast to grow significantly at 93% annually despite past losses increasing over five years by a large margin. Unlock comprehensive insights into our analysis of Antares Vision stock in this financial health report. Evaluate Antares Vision's prospects by accessing our earnings growth report. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Aiforia Technologies Oyj, along with its subsidiary Aiforia Inc., provides deep learning AI software to assist pathologists and scientists in various labs globally, with a market cap of €106.35 million. Operations: The company generates revenue primarily from its Healthcare Software segment, amounting to €2.85 million. Market Cap: €106.35M Aiforia Technologies Oyj, with a market cap of €106.35 million, is navigating the penny stock landscape by leveraging its AI-assisted pathology solutions. Despite being unprofitable and having a modest revenue of €2.85 million, Aiforia's financial health is bolstered by short-term assets (€13.2M) exceeding liabilities and more cash than debt. Recent strategic partnerships with institutions like Nantes University Hospital and USCAP highlight its expanding footprint in digital pathology. The company recently raised €8 million through equity offerings, extending its cash runway to support operations amid management changes and ongoing efforts to enhance product adoption globally. Take a closer look at Aiforia Technologies Oyj's potential here in our financial health report. Gain insights into Aiforia Technologies Oyj's outlook and expected performance with our report on the company's earnings estimates. Simply Wall St Financial Health Rating: ★★★★★★ Overview: KebNi AB (publ) is a company that develops, produces, and sells stabilization, navigation, and satellite communication products globally with a market cap of SEK492.96 million. Operations: The company's revenue is primarily derived from its Unclassified Services segment, amounting to SEK141.66 million. Market Cap: SEK492.96M KebNi AB, with a market cap of SEK492.96 million, is making strides in the penny stock sector through its satellite communication products and stabilization technology. The company has recently secured a significant order from Saab worth 134 MSEK for its Inertial Measurement Units, contributing to total orders of 348 MSEK over 30 months. Despite past volatility and insider selling, KebNi's financial position remains robust with short-term assets exceeding liabilities and no debt burden. While profitability has been achieved recently, earnings growth comparisons are challenging due to large one-off losses impacting results up to March 2025. Click here to discover the nuances of KebNi with our detailed analytical financial health report. Gain insights into KebNi's future direction by reviewing our growth report. Investigate our full lineup of 447 European Penny Stocks right here. Curious About Other Options? We've found 19 US stocks that are forecast to pay a dividend yeild of over 6% next year. See the full list for free. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include BIT:AV HLSE:AIFORIA and OM:KEBNI B. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
35 minutes ago
- Yahoo
Estimating The Intrinsic Value Of Symrise AG (ETR:SY1)
Symrise's estimated fair value is €111 based on 2 Stage Free Cash Flow to Equity Symrise's €105 share price indicates it is trading at similar levels as its fair value estimate The €115 analyst price target for SY1 is 4.0% more than our estimate of fair value Does the June share price for Symrise AG (ETR:SY1) reflect what it's really worth? Today, we will estimate the stock's intrinsic value by estimating the company's future cash flows and discounting them to their present value. We will take advantage of the Discounted Cash Flow (DCF) model for this purpose. Believe it or not, it's not too difficult to follow, as you'll see from our example! Companies can be valued in a lot of ways, so we would point out that a DCF is not perfect for every situation. If you want to learn more about discounted cash flow, the rationale behind this calculation can be read in detail in the Simply Wall St analysis model. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. We are going to use a two-stage DCF model, which, as the name states, takes into account two stages of growth. The first stage is generally a higher growth period which levels off heading towards the terminal value, captured in the second 'steady growth' period. To begin with, we have to get estimates of the next ten years of cash flows. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years. Generally we assume that a dollar today is more valuable than a dollar in the future, and so the sum of these future cash flows is then discounted to today's value: 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 Levered FCF (€, Millions) €546.9m €577.2m €625.7m €700.5m €710.0m €718.9m €727.9m €737.1m €746.4m €755.8m Growth Rate Estimate Source Analyst x6 Analyst x7 Analyst x6 Analyst x2 Analyst x1 Est @ 1.25% Est @ 1.26% Est @ 1.26% Est @ 1.26% Est @ 1.26% Present Value (€, Millions) Discounted @ 5.5% €518 €518 €532 €565 €542 €520 €499 €479 €459 €441 ("Est" = FCF growth rate estimated by Simply Wall St)Present Value of 10-year Cash Flow (PVCF) = €5.1b We now need to calculate the Terminal Value, which accounts for all the future cash flows after this ten year period. For a number of reasons a very conservative growth rate is used that cannot exceed that of a country's GDP growth. In this case we have used the 5-year average of the 10-year government bond yield (1.3%) to estimate future growth. In the same way as with the 10-year 'growth' period, we discount future cash flows to today's value, using a cost of equity of 5.5%. Terminal Value (TV)= FCF2034 × (1 + g) ÷ (r – g) = €756m× (1 + 1.3%) ÷ (5.5%– 1.3%) = €18b Present Value of Terminal Value (PVTV)= TV / (1 + r)10= €18b÷ ( 1 + 5.5%)10= €10b The total value is the sum of cash flows for the next ten years plus the discounted terminal value, which results in the Total Equity Value, which in this case is €16b. To get the intrinsic value per share, we divide this by the total number of shares outstanding. Relative to the current share price of €105, the company appears about fair value at a 5.4% discount to where the stock price trades currently. Remember though, that this is just an approximate valuation, and like any complex formula - garbage in, garbage out. We would point out that the most important inputs to a discounted cash flow are the discount rate and of course the actual cash flows. You don't have to agree with these inputs, I recommend redoing the calculations yourself and playing with them. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Symrise as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 5.5%, which is based on a levered beta of 0.987. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business. View our latest analysis for Symrise Strength Earnings growth over the past year exceeded the industry. Debt is well covered by earnings and cashflows. Dividends are covered by earnings and cash flows. Weakness Dividend is low compared to the top 25% of dividend payers in the Chemicals market. Opportunity Annual earnings are forecast to grow for the next 3 years. Current share price is below our estimate of fair value. Threat Annual earnings are forecast to grow slower than the German market. Valuation is only one side of the coin in terms of building your investment thesis, and it ideally won't be the sole piece of analysis you scrutinize for a company. It's not possible to obtain a foolproof valuation with a DCF model. Instead the best use for a DCF model is to test certain assumptions and theories to see if they would lead to the company being undervalued or overvalued. If a company grows at a different rate, or if its cost of equity or risk free rate changes sharply, the output can look very different. For Symrise, there are three further elements you should further examine: Risks: To that end, you should be aware of the 1 warning sign we've spotted with Symrise . Future Earnings: How does SY1's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart. Other Solid Businesses: Low debt, high returns on equity and good past performance are fundamental to a strong business. Why not explore our interactive list of stocks with solid business fundamentals to see if there are other companies you may not have considered! PS. Simply Wall St updates its DCF calculation for every German stock every day, so if you want to find the intrinsic value of any other stock just search here. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Lazard Opens New UK Headquarters in Historic Manchester Square, W1
Lazard opens new, larger headquarters at 20 Manchester Square, extending the firm's near 150-year history in the UK Move reflects Lazard's continued commitment to the UK and London as one of the world's pre-eminent financial centres LONDON, June 02, 2025--(BUSINESS WIRE)--Lazard, Inc. (NYSE: LAZ) announced today that its new UK headquarters opened at 20 Manchester Square, housing both the firm's Financial Advisory and Asset Management businesses. The new, larger office reflects Lazard's commitment to London as one of the world's leading financial centres and the firm's continued growth in Europe. 20 Manchester Square will become part of Lazard's European footprint and one of its three main global offices, alongside New York and Paris. As a cornerstone of Lazard's international network, the new UK HQ extends the firm's long-standing presence in London which dates back to 1877. Cyrus Kapadia, Co-Head of European Investment Banking and CEO of UK Financial Advisory, said: "The move to 20 Manchester Square underscores our unwavering commitment to the UK and our deep-rooted heritage in London. We have been successfully growing our European teams and network to further support our clients across Europe and around the globe." Jeremy Taylor, CEO of Lazard UK Asset Management said, "20 Manchester Square is more than just a new office—it's a reflection of our values and vision. We are committed to delivering exceptional performance for our clients. This new UK headquarters embodies our dedication to innovation, collaboration, and thoughtful stewardship as we continue to best serve the needs of our clients." The new building offers modern office space and has been designed with an emphasis on innovation and sustainable standards of construction, technology and use. The space has renewable energy from solar panels on the roof and a rainwater harvesting system. The building's construction adhered to the UK Green Building Council framework for net-zero carbon emissions and recycled, long-life materials with reduced replaceability have been used across floors, walls and ceiling finishes, with water efficient taps, showers and fixtures in place throughout. 20 Manchester Square is situated next door to the Wallace Collection and Regent's Park, and the area is well known for its cultural landmarks and accessible transport links. Lazard UK is relocating from 50 Stratton Street, after over twenty years. ABOUT LAZARD Founded in 1848, Lazard is the preeminent financial advisory and asset management firm, with operations in North and South America, Europe, the Middle East, Asia, and Australia. Lazard provides advice on mergers and acquisitions, capital markets and capital solutions, restructuring and liability management, geopolitics, and other strategic matters, as well as asset management and investment solutions to institutions, corporations, governments, partnerships, family offices, and high net worth individuals. For more information, please visit and follow Lazard on LinkedIn. View source version on Contacts MEDIA CONTACTS Poppy Trowbridge, Financial Advisory+44 207 187 Zoe Butt, Asset Management+44 20 7448 INVESTOR CONTACT Alexandra Deignan+1 212 632 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
